Acadian Asset Management
IPSC icon

Acadian Asset Management’s Century Therapeutics IPSC Stock Holding History

Acadian Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-278,075
Closed -$627K – 2101
2026
Q1 		$627K Sell
278,075
-939,028
-77% -$1.97M ﹤0.01% 1303
2025
Q4 		$1.21M Buy
1,217,103
+497,295
+69% +$303K ﹤0.01% 1057
2025
Q3 		$357K Buy
719,808
+412,711
+134% +$222K ﹤0.01% 1292
2025
Q2 		$170K Buy
307,097
+22,868
+8% +$12.3K ﹤0.01% 1326
2025
Q1 		$133K Buy
284,229
+142,953
+101% +$107K ﹤0.01% 1311
2024
Q4 		$142K Buy
141,276
+21,892
+18% +$29.8K ﹤0.01% 1309
2024
Q3 		$202K Buy
+119,384
New +$234K ﹤0.01% 1357
2024
Q1 		– Sell
-6,947
Closed -$23K – 1675
2023
Q4 		$23K Sell
6,947
-39,926
-85% -$72.7K ﹤0.01% 1578
2023
Q3 		$92K Sell
46,873
-3,205
-6% -$8.53K ﹤0.01% 1318
2023
Q2 		$157K Sell
50,078
-11,434
-19% -$36.9K ﹤0.01% 1319
2023
Q1 		$212K Buy
+61,512
New +$270K ﹤0.01% 1242

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Acadian Asset Management's IPSC Position: Q2 2026 in Review

Acadian Asset Management sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 278,075 shares — an estimated $627K sold.

Acadian Asset Management first reported a position in IPSC in Q1 2023 and held it in 11 quarters. The position peaked at $1.21M in Q4 2025. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Acadian Asset Management reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 278,075 Century Therapeutics shares in Q2 2026, an estimated $627K.
  • Acadian Asset Management first reported a position in Century Therapeutics in Q1 2023 and held it in 11 quarters.
  • Acadian Asset Management's Century Therapeutics position peaked at $1.21M in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.